Dr Jeffrey Liddell
Research Fellow
Department of Anatomy and Physiology
60 Scholarly works
12 Projects
HIGHLIGHTS
2026
Journal article
Decreased metallothionein-3 expression in the human spinal cord is a common feature of amyotrophic lateral sclerosis and multiple sclerosis
DOI: 10.1038/s41598-025-31283-92025
Journal article
Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine model
DOI: 10.1007/s00401-025-02859-62024
Journal article
Evidence for disrupted copper availability in human spinal cord supports CuII(atsm) as a treatment option for sporadic cases of ALS
DOI: 10.1038/s41598-024-55832-w2024
Journal article
Integrated elemental analysis supports targeting copper perturbations as a therapeutic strategy in multiple sclerosis
DOI: 10.1016/j.neurot.2024.e004322023
Research grants (other domestic)
Multiomic Interrogation of Patient-Derived Neurotoxic Glia
2022
Research grants (other domestic)
Transcriptomic and Proteomic Characterisation of Glial Ferroptosis as a Cause of Non-Cell Autonomous Neuronal Death
2019
Research Grant
The Neurotoxic Consequences of Glial Iron Accumulation in MND
RECENT SCHOLARLY WORKS
2024
Journal article
Decreased spinal cord motor neuron numbers in mice depleted of central nervous system copper
DOI: 10.1093/mtomcs/mfae0362024
Journal article
Patient-Derived Blood-Brain Barrier Model for Screening Copper Bis(thiosemicarbazone) Complexes as Potential Therapeutics in Alzheimer’s Disease
DOI: 10.1021/acschemneuro.3c007432024
Journal article
Microglial ferroptotic stress causes non-cell autonomous neuronal death
DOI: 10.1186/s13024-023-00691-82024
Journal article
Evidence for decreased copper associated with demyelination in the corpus callosum of cuprizone-treated mice
DOI: 10.1093/mtomcs/mfad0722023
Journal article
Fundamental Neurochemistry Review: Copper availability as a potential therapeutic target in progressive supranuclear palsy: Insight from other neurodegenerative diseases
DOI: 10.1111/jnc.159782023
Journal article
CuII(atsm) significantly decreases microglial reactivity in patients with sporadic amyotrophic lateral sclerosis
DOI: 10.1111/nan.12938
RECENT PROJECTS
2022
Research Grant
Identifying the Glial Neurotoxic Factors Responsible for Neurodegeneration
2014
Research Grant
Agents Targeting Iron in the Brain in Parkinson's Disease